1. Home
  2. XBIT vs CFBK Comparison

XBIT vs CFBK Comparison

Compare XBIT & CFBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo XBiotech Inc.

XBIT

XBiotech Inc.

N/A

Current Price

$2.20

Market Cap

66.8M

Sector

Health Care

ML Signal

N/A

Logo CF Bankshares Inc.

CFBK

CF Bankshares Inc.

N/A

Current Price

$33.85

Market Cap

228.3M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
XBIT
CFBK
Founded
2005
1892
Country
United States
United States
Employees
N/A
N/A
Industry
Pharmaceuticals and Biotechnology
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
66.8M
228.3M
IPO Year
2015
2005

Fundamental Metrics

Financial Performance
Metric
XBIT
CFBK
Price
$2.20
$33.85
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 36.5K
27.5K
Earning Date
11-11-2026
11-02-2026
Dividend Yield
N/A
★ 1.06%
EPS Growth
N/A
★ 30.58
EPS
N/A
★ 1.67
Revenue
N/A
N/A
Revenue This Year
N/A
$7.47
Revenue Next Year
$30.47
$12.06
P/E Ratio
★ N/A
$20.43
Revenue Growth
N/A
★ N/A
52 Week Low
$2.09
$22.10
52 Week High
$3.44
$38.11

Technical Indicators

Market Signals
Indicator
XBIT
CFBK
Relative Strength Index (RSI) 47.52 38.47
Support Level $2.16 $33.84
Resistance Level $2.48 $33.97
Average True Range (ATR) 0.04 0.76
MACD 0.01 -0.11
Stochastic Oscillator 66.67 4.56

Price Performance

Historical Comparison
XBIT
CFBK

About XBIT XBiotech Inc.

XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.

About CFBK CF Bankshares Inc.

CF Bankshares Inc is engaged in the provision of a variety of financial services. It provides personalized business banking products and services, including commercial loans and leases, commercial and residential real estate loans, equipment leasing, SBA loans, and treasury management depository services. The revenues are derived principally from the interest and fees on loans originated and noninterest income generated on the sale of loans.

Share on Social Networks: